Orphan designation: (1R,2S) 6-bromo-alpha-[2-(dimethylamino)ethyl]-2-methoxy-alpha-(1-naphthyl)-beta-phenyl-3-quinolineethanol bedaquiline Treatment of tuberculosis, 26/08/2005 Withdrawn

Multi-stakeholder workshop on Data Quality Framework for Adverse Drug Reaction reporting, Online, European Medicines Agency, Amsterdam, the Netherlands, Broadcast, from 1 March 2024, 09:30 (CET) to 1 March 2024, 15:40 (CET)

CTIS Bitesize Talk: How to submit a transitional trial in CTIS, Online, Broadcast, from 29 February 2024, 16:30 (CET) to 29 February 2024, 18:00 (CET)

Coordination of pharmacovigilance inspections

Applications for new human medicines under evaluation: March 2024

DARWIN EU Advisory Board: Membership

Human medicines European public assessment report (EPAR): Pramipexole Accord, pramipexole, Date of authorisation: 29/09/2011, Revision: 10, Status: Withdrawn

Veterinary medicines European public assessment report (EPAR): Innovax-ILT-IBD, turkey herpes virus, expressing infectious bursal disease virus and avian infectious laryngotracheitis virus, strain HVT/IBD/ILT, live, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Prevexxion RN+HVT, Marek’s disease virus, strain RN1250, live,Turkey herpesvirus, strain FC126, Live, Status: Authorised

Veterinary medicines European public assessment report (EPAR): Eurican L4, inactivated immunological veterinary medicinal product containing Leptospira interrogans, serogroup Canicola, serovar Canicola, strain 16070, L. interrogans, serogroup icterohaemorrhagiae, serovar icterohaemorrhagiae, strain 16069, L. interrogans, serogroup Grippotyphosa, serovar Grippotyphosa, strain Grippo Mal 1540, L. interrogans, serogroup Australis, serovar Bratislava, strain, Status: Authorised